Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2001, p. 1014-1021, Vol. 45, No. 4
PH-R Ai2 Virology, Bayer AG,
Wuppertal,1 and Institut für
Pharmazeutische Technologie, Universität Frankfurt am Main,
Frankfurt am Main,2 Germany
Received 27 July 2000/Returned for modification 30 November
2000/Accepted 3 January 2001
The report describes the establishment and characterization of a
mouse xenograft transplantation model for the study of papillomavirus infection of bovine skin. Calf scrotal skin was inoculated with bovine
papillomavirus type 2 before grafting it to the dorsum of severe
combined immunodeficient mice. The grafted skin contained epidermis,
dermis, and a thin layer of fat. After 5 months the induced warts not
only showed histological features of papillomavirus infections but also
tested positive for viral DNA and papillomavirus capsid antigen. The
formation of infectious virions was demonstrated by inoculation of new
transplants with crude extract from the induced warts as well as in a
cell culture focus assay. Topical application of
bromovinyl-2'-deoxyuridine led to a reduction in viral DNA content in
the developing wart. This small-animal xenograft model should be useful
for characterizing antiviral compounds and providing an understanding
of the regulation of papillomavirus infections.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.4.1014-1021.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Xenograft Model for Identifying Chemotherapeutic
Agents against Papillomaviruses
*
Corresponding author. Mailing address: Bayer AG, PH-R
Ai2, P.O. Box 101709, 42096 Wuppertal, Germany. Phone: 49-202-368411. Fax: 49-202-364162. E-mail:
guy.hewlett.gh{at}bayer-ag.de.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |